Bitistatin-functionalized fluorescent nanodiamond particles specifically bind to purified human platelet integrin receptor &alpha;<sub>IIb</sub>&beta;<sub>3</sub> and activated platelets

Cezary Marcinkiewicz; Jonathan A Gerstenhaber; Mark Sternberg; Peter I Lelkes; Giora Feuerstein

doi:10.2147/IJN.S134128

open access to scientific and medical research

Back to Journals » International Journal of Nanomedicine » Volume 12

Original Research

Bitistatin-functionalized fluorescent nanodiamond particles specifically bind to purified human platelet integrin receptor α_IIbβ₃ and activated platelets

Total article views		HTML views	PDF downloads	Totals
6,582	Dovepress*	6,130+	1,133	7,263
	PubMed Central*	452	165	617
	Totals	6,582	1,298	7,880
*Since 15 May 2017

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.

Bitistatin-functionalized fluorescent nanodiamond particles specifically bind to purified human platelet integrin receptor αIIbβ3 and activated platelets

Bitistatin-functionalized fluorescent nanodiamond particles specifically bind to purified human platelet integrin receptor α_IIbβ₃ and activated platelets